MabPlex is the one of the leading companies for ADC drug development in the world which provides technically challenging service from development to commercial production including both payload and ADC. MabPlex has pioneered formulations to effectively manage high-concentration antibodies and proteins, typically plagued by high viscosity, precipitation, and aggregation. Our formulation and fill capacity for ADCs ranks among the top three worldwide.